Watch today’s webcast, where CEO Linda Persson presents NanoEcho’s progress during the third quarter – an eventful period with several significant milestones achieved:
Successful issue and listing on the Nasdaq First North Growth Market – An important milestone that contributes to increased visibility and credibility as well as improved liquidity for our shareholders.
Doubling the number of shareholders – After the listing, interest in NanoEcho has continued to grow and attracted many new shareholders.
Recruitment for clinical study started – After careful and extensive preparations during the quarter, we were proud to announce, shortly after the end of the period, that the recruitment of study participants for the dose confirmation study has started.
These successes reflect NanoEcho’s single-mindedness and focus on responsibility, commitment and reliable delivery. The presentation was arranged by G&W Fondkommission!
